As Pfizer gears up for its next big vaccine launch in Prevnar 20, the company is touting positive top-line results for a co-administration trial with a seasonal flu shot. The results, coming just ahead of the flu season, could give the company's new vaccine an early boost.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,